Close Menu
Home » Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study

Biocartis, AstraZeneca Partner on European Lung Cancer Biomarker Study

Nov 29, 2018
|
staff reporter

NEW YORK (GenomeWeb) – Biocartis announced today that it has partnered with AstraZeneca on a European study designed to obtain faster lung cancer molecular diagnostics results.

As part of the agreement, the firms will begin a prospective lung cancer study using Biocartis' Idylla EGFR mutation test in European countries including Belgium, France, Germany, and Italy.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

Aug
22
Featured Webinar

Biobanks and the Rise of Precision Medicine: Lessons from the Estonian Biobank

Sponsored by
BC Platforms

This webinar will discuss how the Estonian Biobank, a cohort of more than 165,000 participants, is addressing industry challenges with data management and collaboration in the transition to precision medicine.

Aug
28
Featured Webinar

Beyond Cas9: CRISPR Gene Editing with Alternative Nucleases

Sponsored by
Horizon Discovery

This webinar will provide an overview of alternatives to the popular Cas9 nuclease used in CRISPR gene editing.

Sep
18
Featured Webinar

Highly Sensitive Structural Variant Detection for Medical Genetics: A Comparison to the Standard of Care

Sponsored by
Bionano Genomics

This webinar will outline how a team at Radboud University Medical Center is assessing ultra-long read optical mapping on the Bionano Saphyr system to replace classical cytogenetics approaches in routine testing and for the discovery of novel structural variants with potential scientific, prognostic, or therapeutic value that are missed by standard approaches.

Oct
23
Featured Webinar

Single-Cell Methylation Profiling of Pediatric Tumors via a Unique NGS-based Approach

Sponsored by
Swift Biosciences

This webinar will illustrate how single-cell methylation sequencing can be applied to gain significant insight into epigenetic heterogeneity in disease states, advancing cancer research discoveries. 

What's Popular?

In Cancer

  1. Foundation Medicine to Seek FDA Approval for FoundationOne as CDx to Genentech's Rozlytrek

  2. Complex Genetic Testing Errors Emerge Amid Increasing Panel Use, Consumer Access, Case Series Finds

    Premium

  3. Actionable Mutation Analysis Reveals Germline Risk in Older CRC Patients

  4. Adaptive Biotechnologies Plans New Product Launches, Expanded FDA Label for ClonoSeq

    Premium

  5. OncoCyte Q2 Net Loss Rises

Sponsorships

Privacy Policy.  Terms & Conditions.  Copyright © 2019 GenomeWeb LLC.  All Rights Reserved.